vTv Therapeutics Inc. Cl A | Income Statement
Fiscal year is January-December. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
1,549.00
519.00
634.00
291.00
12,434
SG&A Expense
29,582.00
38,160.00
55,389.00
50,776.00
32,040
EBIT
28,897.00
38,142.00
55,020.00
50,682.00
19,824
Unusual Expense
-
695.00
-
-
638
Non Operating Income/Expense
1,195.00
535.00
22.00
190.00
46
Interest Expense
6,009.00
1,735.00
398.00
3,092.00
3,290
Pretax Income
36,101.00
41,107.00
55,353.00
53,847.00
23,645
Income Tax
-
-
-
800.00
200
Consolidated Net Income
235,461.00
41,107.00
55,353.00
54,647.00
24,584
Net Income
235,461.00
27,498.00
16,352.00
16,144.00
8,650
Net Income After Extraordinaries
235,461.00
27,498.00
16,352.00
16,144.00
8,650
Net Income Available to Common
235,461.00
27,498.00
16,352.00
16,144.00
8,650
EPS (Basic)
6.93
3.32
1.71
1.67
0.69
Basic Shares Outstanding
33,984.40
8,276.50
9,545.50
9,693.30
12,449.20
EPS (Diluted)
6.93
3.32
1.71
1.67
0.69
Diluted Shares Outstanding
33,984.40
8,276.50
9,545.50
9,693.30
12,449.20
EBITDA
28,033.00
37,641.00
54,755.00
50,485.00
19,606
Non-Operating Interest Income
-
-
87.00
117.00
61
Minority Interest Expense
-
13,609.00
39,001.00
38,503.00
15,934
Other After Tax Income (Expense)
199,360.00
-
-
-
739
About vTv Therapeutics
View Profile
